icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
2019 April 10-14
Vienna Austria
Back grey_arrow_rt.gif
 
 
 
The socio-economic burden of NASH in Europe and the United States: the GAIN study
 
 
  - High Resource Use & Medical Costs Per Patient
 
- Indirect Costs to Patients & Caregivers, Productivity Losses Dwarf the Medical Costs....."Costs to Society for an untreated NASH population"
 
Presented by Jamie O'Hara
 
A retrospective and cross-sectional research study
Sponsorship received from
Novo Nordisk & Gilead
 
Tom Russell, Senior Consultant, HCD Economics
Rosa Willock, Project Manager , HCD Economics
Leo Ruiz, Senior Economist, HCD Economics
George Morgan, Health Economist, HCD Economics
Bethany Franks, RWE researcher, HCD Economics
Jamie O'Hara, CEO, HCD Economics
 
Reported by Jules Levin
EASL 2019
April 10-14 Vienna

0426191

0426192

0426193

0426194

0426195

0426196

0426197

0426198

0426199